Derivative exercise or conversion — not an open-market buy.
Traded Aug 28, 2026 · Filed Aug 31, 2026
Synopsys's EXECUTIVE CHAIR sold $11.1M of Synopsys shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$11,138,755
Shares × reported transaction price
2 days after results of Aug 26, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $442.61 on Aug 28, 2026, 19% above its 52-week low and 27% below its high, after a 15% rise over the previous 30 trading days
52-week range $372.33 (Jul 30, 2026) to $609.08 (Sep 8, 2025), 30% of the way up, from 251 adjusted closes. 30 trading days earlier: $384.275 on Jul 17, 2026. Describes the past only, not a forecast
A WARN layoff notice covering 128 workers was filed in California on August 31, 2026.
From the official state WARN list, 3 days after the trade. Shown for timing only; the two filings are separate
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Oct 31, 2025 in the U.S. District Court, N.D. California. A filing is an allegation, not a finding.
In re Synopsys, Inc. Securities Litigation, docket 5:25-cv-09410, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -5.5% | +0.6% | -6.0% |
| 30 days | +18.3% | +0.3% | +18.0% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
The boss of Synopsys sold $5.47M of Synopsys shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.